首页 | 本学科首页   官方微博 | 高级检索  
检索        


Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized,placebo‐controlled trial
Authors:Pelle L Ishøy MD  Filip K Knop MD  PhD  Brian V Broberg PhD  Nikolaj Bak PhD  Ulrik B Andersen MD  Niklas R Jørgensen MD DMSc  Jens J Holst MD  DMSc  Birte Y Glenthøj MD DMSc  Bjørn H Ebdrup MD  PhD
Institution:1. Center for Neuropsychiatric Schizophrenia Research, CNSR, and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark;2. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;3. Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark;4. The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;5. Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Glostrup, Denmark;6. Research Center for Ageing and Osteoporosis, Departments of Clinical Biochemistry and Medicine, Rigshospitalet, University of Copenhagen, Glostrup, Denmark;7. OPEN, Odense Patient Data Explorative Network, Odense University Hospital/Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Abstract:
Keywords:antidiabetic drug  exenatide     GLP‐1 analogue  randomized trial schizophrenia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号